Literature DB >> 20697132

The process of NCCN guidelines adaptation to the Middle East and North Africa region.

Abdul-Rahman Jazieh1, Hamdy A Azim, Joan McClure, Mohammad Jahanzeb.   

Abstract

The NCCN developed clinical practice guidelines for oncology that set the standard of cancer care in the United States. Because of wide acceptance of, need for, and interest in standardized treatment practices across the world, NCCN launched initiatives to help international groups adapt these guidelines. This article describes the initiative in the Middle East and North Africa (MENA) region. A group of oncology experts and key opinion leaders were assembled into 7 specific committees to develop treatment guidelines for breast cancer, lung cancer, colon cancer, prostate cancer, hepatobiliary cancer, lymphoma, and palliative care. The committees reviewed the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) to identify any modifications required for them to be more applicable to the MENA region based on available evidence and regional experience. These modifications were discussed with NCCN experts and summarized for each specific area. The development of these guidelines generated a strong interest in the region to develop more evidence-based practice and create further networking and collaboration.

Entities:  

Mesh:

Year:  2010        PMID: 20697132     DOI: 10.6004/jnccn.2010.0125

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  7 in total

Review 1.  Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials.

Authors:  M Mura Assifi; Xuyang Lu; Guido Eibl; Howard A Reber; Gang Li; O Joe Hines
Journal:  Surgery       Date:  2011-09       Impact factor: 3.982

2.  Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma.

Authors:  Erin R DeRose; Alexander Pleet; Wei Wang; Virginia J Seery; Mee Young Lee; Sharon Renzi; Ryan J Sullivan; Michael B Atkins
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

3.  The advantages and limitations of guideline adaptation frameworks.

Authors:  Zhicheng Wang; Susan L Norris; Lisa Bero
Journal:  Implement Sci       Date:  2018-05-29       Impact factor: 7.327

Review 4.  Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting.

Authors:  Fernando Cotait Maluf; Graziela Zibetti Dal Molin; Andreia Cristina de Melo; Eduardo Paulino; Douglas Racy; Robson Ferrigno; Pedro Luiz Serrano Uson Junior; Reitan Ribeiro; Renato Moretti; Jose Carlos Sadalla; Angelica Nogueira-Rodrigues; Filomena Marino Carvalho; Glauco Baiocchi; Donato Callegaro-Filho; Nadeem R Abu-Rustum
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

5.  Recommendations for the treatment of vulvar cancer in settings with limited resources: Report from the International Gynecological Cancer Society consensus meeting.

Authors:  Fernando Cotait Maluf; Graziela Dal Molin Zibetti; Eduardo Paulino; Andreia Cristina de Melo; Douglas Racy; Robson Ferrigno; Pedro Luiz Serrano Uson Junior; Reitan Ribeiro; Renato Moretti; Jose Carlos Sadalla; Angelica Nogueira Rodrigues; Filomena Marino Carvalho; Glauco Baiocchi; Donato Callegaro-Filho; Roberto Angioli
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

6.  Saudi Oncology Society clinical management guidelines development.

Authors:  Shouki N Bazarbashi
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

7.  Saudi lung cancer management guidelines 2017.

Authors:  Abdul Rahman Jazieh; Khaled Al Kattan; Ahmed Bamousa; Ashwaq Al Olayan; Ahmed Abdelwarith; Jawaher Ansari; Abdullah Al Twairqi; Turki Al Fayea; Khalid Al Saleh; Hamed Al Husaini; Nafisa Abdelhafiez; Mervat Mahrous; Medhat Faris; Ameen Al Omair; Adnan Hebshi; Salem Al Shehri; Foad Al Dayel; Hanaa Bamefleh; Walid Khalbuss; Sarah Al Ghanem; Shukri Loutfi; Azzam Khankan; Meshael Al Rujaib; Majed Al Ghamdi; Nagwa Ibrahim; Abdulmonem Swied; Mohammad Al Kayait; Marie Datario
Journal:  Ann Thorac Med       Date:  2017 Oct-Dec       Impact factor: 2.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.